New dual-target PET probe aims to sharpen cancer imaging
NCT ID NCT07385950
First seen Feb 04, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tests a new radioactive imaging agent called 68Ga-B6FA-01, designed to make PET/CT scans more accurate for detecting and staging solid tumors. The probe targets two different markers found on cancer cells and their surroundings, which may improve image clarity. About 100 adults with newly diagnosed or recurrent solid tumors will receive the probe and undergo PET/CT imaging. The goal is to see if this method can help doctors diagnose and plan treatment more precisely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430071, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.